Skip to content

Anxiety: all studies

Page 463 of 770: studies 4,621 to 4,630 of 7,695, newest first. Back to the anxiety overview

Research

(2R,6R)-hydroxynorketamine alleviates PTSD-like endophenotypes by regulating the PI3K/AKT signaling pathway in rats.

Pharmacology, Biochemistry, and Behavior December 1, 2024 Lifen Liu, Rui Li, Lanxia Wu et al. 3 citations

Patients diagnosed with post-traumatic stress disorder (PTSD) mainly exhibit enduring adverse emotions, heightening susceptibility to suicidal thoughts and behaviors. Notably, metabolites of ketamine, particularly (2R,6R)-hydroxyketamine (HNK), have demonstrated favorable antidepressant properties. However, the precise mechanism through which HNK exerts its therapeutic effects on negative...

Exploring the regulatory framework of psychedelics in the US & Europe.

Asian Journal of Psychiatry December 1, 2024 Hitesh Kumar Behera, Ramesh Joga, Sravani Yerram et al.

Psychedelic drug therapy has gained prominence for its potential in treating various mental health conditions, including depression, post-traumatic stress disorder (PTSD), and anxiety. Psychedelic treatment differs from conventional psychiatric approaches in mode of action, legal status, and treatment approach. This work delves into the therapeutic potential, mechanisms, and regulatory...

Traditional Indigenous-Amazonian Therapy Involving Ceremonial Tobacco Drinking as Medicine: A Transdisciplinary Multi-Epistemic Observational Study.

Health Education & Behavior December 1, 2024 Ilana Berlowitz, Ernesto García Torres, Juan Celidonio Ruiz Macedo et al. 3 citations

Although the tobacco plant has been employed as a medicinal and sacred herb by Indigenous cultures across the Americas, its usage drastically changed after the 15th-century colonial arrival; its large-scale commodification and global marketing once brought to Europe lead to hedonic and addictive uses harmful to health. As a consequence, tobacco smoking is now one of the largest public health...

DOI: 10.1177/10901981231213348 (opens in new tab) Full text (opens in new tab) Ayahuasca Mental health therapy Indigenous healing practices Medicinal tobacco +6

Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings

Journal of Student Research November 30, 2024 Arman Fard, Amy N. Cohen

Psychedelics are emerging as an effective way to combat mental health disorders such as anxiety, depression, PTSD, and substance abuse. Psychedelics such as psilocybin can decrease overactivity in regions of the brain that are associated with anxiety and depression; for instance, psilocybin acts as an agonist on brain receptors to induce consciousness-altering neural responses. Compared to...

Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms

The International Journal of Neuropsychopharmacology November 29, 2024 Helen M Collins 18 citations

Abstract Psychedelics are emerging as potential treatments for a range of mental health conditions, including anxiety and depression, treatment-resistant depression, and substance use disorders. Recent studies have also suggested that the psychedelic psilocybin may be able to treat obsessive–compulsive disorder (OCD). Since the 1960s, case studies have reported improvements to obsessive and...

DOI: 10.1093/ijnp/pyae057 (opens in new tab) Psilocybin Magic mushrooms Obsessive–compulsive disorder Psychedelics hallucinogens +4

Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study

medRxiv Preprint Server November 26, 2024 Bonnie L. Quigley, Adem T. Can, Megan Dutton et al. 1 citation preprint

Ketamine is being actively investigated as a rapid-acting treatment for many conditions with a stress-related psychopathology, including post-traumatic stress disorder (PTSD). The majority of studies regarding ketamine treatment for PTSD to date (including open-label and randomised control trials) have focused on intravenous (IV) ketamine administration. This administration route has...

DOI: 10.1101/2024.11.26.24318024 (opens in new tab) Full text (opens in new tab) Low-dose oral ketamine PTSD Treatment PTSD Therapy PTSD Relief +8

The Influence of Mindfulness Therapy on Nurse Stress in Hospitals

Jurnal Penelitian Pendidikan IPA November 25, 2024 Letti Kumajas, Shanti Wardhaningsih

The increasing workload, attributed to a high number of patients and limited human resources, is a major cause of stress among nurses. This stress can lead to burnout syndrome, characterized by emotional exhaustion, depersonalization, and a decrease in personal accomplishment, ultimately affecting the quality of nursing care provided to patients. Instances of nurse stress are not confined to a...

Safety pharmacology of acute mescaline administration in healthy participants.

British Journal of Clinical Pharmacology November 25, 2024 Aaron Klaiber, Mélusine Humbert‐droz, Laura Ley et al. 6 citations

Psychedelics, including mescaline, may serve as novel treatments for depression and anxiety. However, data is scarce on the safety of mescaline. The present pooled analysis included two double-blind, randomized, placebo-controlled studies with a total of 48 participants and 96 mescaline administrations. Single oral-dose administrations (n = 16/dose) of mescaline at doses of 100-800 mg were...

Mindfulness Meditation Reduces Stress and Hospital Stay in Gastrointestinal Tumor Patients During Perioperative Period.

Medical Science Monitor November 24, 2024 Xuelian Wang, Yinzhong Lu, Chunhong Gu et al. 3 citations

BACKGROUND The study aims to explored the impact of short-term mindfulness meditation training on physiological and psychological stress levels in patients with gastrointestinal tumors during the perioperative period. MATERIAL AND METHODS We randomly allocated 78 participants to either the experimental group (n=39) or the control group (n=39). The control group received perioperative nursing,...

Maintenance Intramuscular Ketamine-Assisted Psychotherapy, a Retrospective Chart Review of Efficacy, Adverse Events, and Dropouts from a Community Practice.

Journal of Psychoactive Drugs November 22, 2024 Wesley C Ryan, Boris D. Heifets 2 citations

The use of ketamine and ketamine-assisted psychotherapy (KAP) for treatment of depression has grown dramatically, though much of these data are short term. The clinical profile of maintenance treatment remains poorly characterized. We assessed maintenance KAP for efficacy, tolerability, and reasons for dropout. This observational study retrospectively analyzed electronic health records from an...